Ycg LLC Grows Stock Position in CME Group Inc. (NASDAQ:CME)

YCG LLC raised its stake in CME Group Inc. (NASDAQ:CME - Free Report) by 5.9% in the 3rd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 128,552 shares of the financial services provider's stock after buying an additional 7,209 shares during the quarter. CME Group makes up approximately 2.2% of YCG LLC's investment portfolio, making the stock its 20th largest position. YCG LLC's holdings in CME Group were worth $28,365,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other hedge funds have also modified their holdings of CME. Harbor Capital Advisors Inc. increased its position in shares of CME Group by 0.6% during the 3rd quarter. Harbor Capital Advisors Inc. now owns 7,810 shares of the financial services provider's stock worth $1,723,000 after purchasing an additional 45 shares during the last quarter. CVA Family Office LLC increased its position in shares of CME Group by 11.8% during the 3rd quarter. CVA Family Office LLC now owns 436 shares of the financial services provider's stock worth $96,000 after purchasing an additional 46 shares during the last quarter. Lester Murray Antman dba SimplyRich grew its position in CME Group by 0.7% in the 2nd quarter. Lester Murray Antman dba SimplyRich now owns 7,667 shares of the financial services provider's stock valued at $1,507,000 after acquiring an additional 50 shares in the last quarter. Quent Capital LLC grew its position in CME Group by 10.2% in the 3rd quarter. Quent Capital LLC now owns 593 shares of the financial services provider's stock valued at $131,000 after acquiring an additional 55 shares in the last quarter. Finally, Grove Bank & Trust grew its position in CME Group by 1.3% in the 3rd quarter. Grove Bank & Trust now owns 4,276 shares of the financial services provider's stock valued at $943,000 after acquiring an additional 55 shares in the last quarter. 87.75% of the stock is currently owned by hedge funds and other institutional investors.

CME Group Stock Performance

Shares of NASDAQ:CME traded up $3.62 during trading on Friday, reaching $225.66. The company had a trading volume of 1,798,000 shares, compared to its average volume of 1,483,283. The firm has a market capitalization of $81.26 billion, a price-to-earnings ratio of 23.73, a price-to-earnings-growth ratio of 5.56 and a beta of 0.55. The company has a debt-to-equity ratio of 0.09, a current ratio of 1.02 and a quick ratio of 1.02. The stock's fifty day moving average price is $221.72 and its 200 day moving average price is $209.86. CME Group Inc. has a fifty-two week low of $190.70 and a fifty-two week high of $230.36.

CME Group (NASDAQ:CME - Get Free Report) last released its earnings results on Wednesday, October 23rd. The financial services provider reported $2.68 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $2.65 by $0.03. CME Group had a return on equity of 13.39% and a net margin of 57.34%. The business had revenue of $1.58 billion for the quarter, compared to analyst estimates of $1.59 billion. During the same quarter in the previous year, the company posted $2.25 earnings per share. The company's revenue for the quarter was up 18.4% compared to the same quarter last year. As a group, equities research analysts predict that CME Group Inc. will post 10.23 EPS for the current year.

CME Group Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, December 27th. Investors of record on Monday, December 9th will be issued a dividend of $1.15 per share. This represents a $4.60 dividend on an annualized basis and a yield of 2.04%. The ex-dividend date is Monday, December 9th. CME Group's dividend payout ratio is presently 48.37%.

Insider Buying and Selling

In other CME Group news, CFO Lynne Fitzpatrick sold 754 shares of the company's stock in a transaction on Sunday, September 15th. The stock was sold at an average price of $216.99, for a total value of $163,610.46. Following the sale, the chief financial officer now owns 13,261 shares of the company's stock, valued at approximately $2,877,504.39. This represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. In other CME Group news, CFO Lynne Fitzpatrick sold 754 shares of the company's stock in a transaction on Sunday, September 15th. The stock was sold at an average price of $216.99, for a total value of $163,610.46. Following the sale, the chief financial officer now owns 13,261 shares of the company's stock, valued at approximately $2,877,504.39. This represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, insider Timothy Francis Mccourt sold 1,374 shares of the company's stock in a transaction on Monday, October 28th. The shares were sold at an average price of $227.12, for a total value of $312,062.88. Following the completion of the sale, the insider now directly owns 7,275 shares in the company, valued at $1,652,298. This trade represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold 15,621 shares of company stock valued at $3,441,063 over the last quarter. Company insiders own 0.30% of the company's stock.

Analysts Set New Price Targets

Several research firms have weighed in on CME. Piper Sandler lifted their target price on CME Group from $240.00 to $250.00 and gave the company an "overweight" rating in a research report on Monday, October 28th. Keefe, Bruyette & Woods lifted their price objective on CME Group from $212.00 to $213.00 and gave the company a "market perform" rating in a research note on Thursday, July 25th. Deutsche Bank Aktiengesellschaft lifted their price objective on CME Group from $193.00 to $200.00 and gave the company a "hold" rating in a research note on Thursday, August 15th. Citigroup lifted their price objective on CME Group from $250.00 to $255.00 and gave the company a "buy" rating in a research note on Thursday, October 24th. Finally, The Goldman Sachs Group lifted their price objective on CME Group from $195.00 to $198.00 and gave the company a "sell" rating in a research note on Thursday, October 3rd. Four equities research analysts have rated the stock with a sell rating, seven have issued a hold rating and four have given a buy rating to the company's stock. According to MarketBeat.com, the stock presently has an average rating of "Hold" and a consensus price target of $222.73.

CME Group Profile

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.